Literature DB >> 8425323

Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect.

W M Gersony1, C J Hayes, D J Driscoll, J F Keane, L Kidd, W M O'Fallon, D R Pieroni, R R Wolfe, W H Weidman.   

Abstract

BACKGROUND: Quality of life of patients with congenital heart defects is an important aspect of the assessment of outcome of medical and surgical treatment. METHODS AND
RESULTS: All participants in the Second Natural History Study of Congenital Heart Defects who completed the study questionnaire were included in this analysis. The questionnaire completed by the patients included inquiries relative to medical history, marital and family life, self-perception of well-being, insurability, and employability. The following general observations were apparent. The study cohort reported a self-perception of health status that was similar to that of the general population. Second, 35-40% of patients had not had a cardiac evaluation within the previous 10 years. Third, 16% of the patients had no health insurance, and 35.7% of the patients had no life insurance. For the patients with pulmonary stenosis and ventricular septal defect, the percent who were married was less than that of the corresponding national age- and sex-specific population. For patients with aortic stenosis, the percent married was greater than that of the general population for some age groups. The proportion of divorced or separated individuals was similar to that of the general population. For all three defects, the level of educational attainment exceeded the national average. Last, unemployment rates were similar to national averages except for women with aortic stenosis, who had a significantly higher unemployment rate than did age- and sex-matched controls.
CONCLUSIONS: Patients initially identified with aortic stenosis, pulmonary stenosis, or ventricular septal defect in 1959-1973 have a quality of life in the mid-1980s similar to that of the general US population.

Entities:  

Mesh:

Year:  1993        PMID: 8425323

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease.

Authors:  M Kamphuis; J Ottenkamp; H W Vliegen; T Vogels; K H Zwinderman; R P Kamphuis; S P Verloove-Vanhorick
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Proposed method for evaluation and categorization of functional capacity of children, adolescents, and adults with cardiac diseases to bring them in existing social justice system by creating the cardiac disability criteria.

Authors:  Smita Mishra; Rajesh Sharma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-24

3.  Health-related quality of life in children attending a cardiology clinic.

Authors:  R E Walker; K Gauvreau; K J Jenkins
Journal:  Pediatr Cardiol       Date:  2003-11-03       Impact factor: 1.655

4.  Quality of life in adults with congenital heart disease.

Authors:  D A Lane; G Y H Lip; T A Millane
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

5.  Coming from behind to win--a qualitative research about psychological conditions of adolescents who have undergone open-heart surgery for single ventricle between the ages 0-5.

Authors:  Oguzhan Zahmacioglu; Cenk Eray Yildiz; Bulent Koca; Murat Ugurlucan; Selman Gokalp; Gurkan Cetin; Ayse Guler Eroglu; Funda Oztunc
Journal:  J Cardiothorac Surg       Date:  2011-11-23       Impact factor: 1.637

6.  Right coronary cusp prolapse resembling subpulmonic stenosis in an old adult patient with ventricular septal defect.

Authors:  Myeong Gun Kim; Wook-Jin Chung; Chang Hyu Choi; Jeonggeun Moon; Mi-Seung Shin; Seung Hwan Han; Eak Kyun Shin
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

Review 7.  Surgical and transcatheter management alternatives in refractory pulmonary hypertension: Potts shunt.

Authors:  Serdar Kula; Vildan Atasayan
Journal:  Anatol J Cardiol       Date:  2015-10       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.